Patients with inflammatory bowel disease (IBD) are at increased risk of developing
colorectal cancer (CRC), despite decreases in CRC incidence in recent years. Chronic …

Inflammatory bowel diseases (IBD), comprising Crohn disease (CD) and ulcerative colitis
(UC), are chronic inflammatory conditions of the gastrointestinal tract driven by inappropriate …

This guideline is the second European Crohn's and Colitis Organisation [ECCO] evidence-
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …

Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an
expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy …

Endoscopic assessment of inflammation and mucosal healing is crucial for appropriate
management in IBD. Current definition of endoscopic mucosal healing has been derived …

Abstract Background and Aims Ulcerative colitis [UC] patients are at an increased risk of
developing colorectal cancer due to chronic inflammation. Endoscopic submucosal …

Background and Aims Inflammatory bowel disease (IBD) is a well-known risk factor for
colorectal cancer (CRC). Current guidelines propose complete endoscopic resection of …

Abstract Background and Aim The feasibility of endoscopic submucosal dissection (ESD) as
a treatment option for dysplasia in ulcerative colitis (UC) has been reported, but the …

Inflammatory bowel disease (IBD) comprising of Crohn's disease (CD) and ulcerative colitis
are chronic inflammatory diseases with a relapsing and remitting course. Complications in …

Background and Aims Current guidelines recommend endoscopic resection of visible and
endoscopically resectable colorectal colitis–associated neoplasia (CAN) in patients with …